Putnam Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.06B | Buy |
|
|||||
|
2023
Q3 | $976M | Buy |
|
|||||
|
2023
Q2 | $840M | Buy |
|
|||||
|
2023
Q1 | $958M | Buy |
|
|||||
|
2022
Q4 | $806M | Buy |
|
|||||
|
2022
Q3 | $760M | Sell |
|
|||||
|
2022
Q2 | $657M | Buy |
|
|||||
|
2022
Q1 | $765M | Sell |
|
|||||
|
2021
Q4 | $849M | Buy |
|
|||||
|
2021
Q3 | $813M | Buy |
|
|||||
|
2021
Q2 | $524M | Buy |
|
|||||
|
2021
Q1 | $310M | Buy |
|
|||||
|
2020
Q4 | $205M | Sell |
|
|||||
|
2020
Q3 | $404M | Buy |
|
|||||
|
2020
Q2 | $436M | Buy |
|
|||||
|
2020
Q1 | $329M | Buy |
|
|||||
|
2019
Q4 | $179M | Buy |
|
|||||
|
2019
Q3 | $699K | Buy |
|
|||||
|
2019
Q2 | $782K | Sell |
|
|||||
|
2019
Q1 | $14.6M | Buy |
|
|||||
|
2018
Q4 | $2.62M | Buy |
|
|||||
|
2018
Q3 | $412K | Sell |
|
|||||
|
2018
Q2 | $393K | Hold |
|
|||||
|
2018
Q1 | $393K | Hold |
|
|||||
|
2017
Q4 | $429K | Sell |
|
|||||
|
2017
Q3 | $101M | Buy |
|
|||||
|
2017
Q2 | $111M | Buy |
|
|||||
|
2017
Q1 | $620K | Hold |
|
|||||
|
2016
Q4 | $587K | Sell |
|
|||||
|
2016
Q3 | $683K | Sell |
|
|||||
|
2016
Q2 | $628K | Buy |
|
|||||
|
2016
Q1 | $613K | Buy |
|
|||||
|
2015
Q4 | $869K | Hold |
|
|||||
|
2015
Q3 | $744K | Sell |
|
|||||
|
2015
Q2 | $867K | Sell |
|
|||||
|
2015
Q1 | $816K | Buy |
|
|||||
|
2014
Q4 | $734K | Sell |
|
|||||
|
2014
Q3 | $1.07M | Sell |
|
|||||
|
2014
Q2 | $899K | Buy |
|
|||||
|
2014
Q1 | $955K | Buy |
|
|||||
|
2013
Q4 | $847K | Sell |
|
|||||
|
2013
Q3 | $1.44M | Buy |
|
|||||
|
2013
Q2 | $1.02M | Buy |
|